148 related articles for article (PubMed ID: 31787688)
1. [Microphysiological system as a promising technology for drug assay].
Ishida S; Kanamori T
Nihon Yakurigaku Zasshi; 2019; 154(6):345-351. PubMed ID: 31787688
[TBL] [Abstract][Full Text] [Related]
2. Multi-functional scaling methodology for translational pharmacokinetic and pharmacodynamic applications using integrated microphysiological systems (MPS).
Maass C; Stokes CL; Griffith LG; Cirit M
Integr Biol (Camb); 2017 Apr; 9(4):290-302. PubMed ID: 28267162
[TBL] [Abstract][Full Text] [Related]
3. The Current Status and Use of Microphysiological Systems by the Pharmaceutical Industry: The International Consortium for Innovation and Quality Microphysiological Systems Affiliate Survey and Commentary.
Baker TK; Van Vleet TR; Mahalingaiah PK; Grandhi TSP; Evers R; Ekert J; Gosset JR; Chacko SA; Kopec AK
Drug Metab Dispos; 2024 Feb; 52(3):198-209. PubMed ID: 38123948
[TBL] [Abstract][Full Text] [Related]
4. Research and Development of Microphysiological Systems in Japan Supported by the AMED-MPS Project.
Ishida S
Front Toxicol; 2021; 3():657765. PubMed ID: 35295097
[TBL] [Abstract][Full Text] [Related]
5. [Toward Regulatory Acceptance of MPS-Cardiac Safety Assessment as an Example].
Yamazaki D
Yakugaku Zasshi; 2023; 143(1):55-63. PubMed ID: 36596540
[TBL] [Abstract][Full Text] [Related]
6. Microphysiological systems in absorption, distribution, metabolism, and elimination sciences.
Van Ness KP; Cesar F; Yeung CK; Himmelfarb J; Kelly EJ
Clin Transl Sci; 2022 Jan; 15(1):9-42. PubMed ID: 34378335
[TBL] [Abstract][Full Text] [Related]
7. Microfluidic Cell Culture Platforms to Capture Hepatic Physiology and Complex Cellular Interactions.
Bale SS; Borenstein JT
Drug Metab Dispos; 2018 Nov; 46(11):1638-1646. PubMed ID: 30115643
[TBL] [Abstract][Full Text] [Related]
8. Technical aspects of microphysiological systems (MPS) as a promising wet human-in-vivo simulator.
Kanamori T; Sugiura S; Sakai Y
Drug Metab Pharmacokinet; 2018 Feb; 33(1):40-42. PubMed ID: 29217459
[TBL] [Abstract][Full Text] [Related]
9. Microphysiological Systems to Assess Nonclinical Toxicity.
Van Ness KP; Chang SY; Weber EJ; Zumpano D; Eaton DL; Kelly EJ
Curr Protoc Toxicol; 2017 Aug; 73():14.18.1-14.18.28. PubMed ID: 28777442
[TBL] [Abstract][Full Text] [Related]
10. Microphysiological Systems: A Pathologist's Perspective.
Sura R; Van Vleet T; Berridge BR
Vet Pathol; 2020 May; 57(3):358-368. PubMed ID: 32180532
[TBL] [Abstract][Full Text] [Related]
11. In vitro microscale systems for systematic drug toxicity study.
Sung JH; Shuler ML
Bioprocess Biosyst Eng; 2010 Jan; 33(1):5-19. PubMed ID: 19701779
[TBL] [Abstract][Full Text] [Related]
12. Human-on-a-chip design strategies and principles for physiologically based pharmacokinetics/pharmacodynamics modeling.
Abaci HE; Shuler ML
Integr Biol (Camb); 2015 Apr; 7(4):383-91. PubMed ID: 25739725
[TBL] [Abstract][Full Text] [Related]
13. Characterization of rat or human hepatocytes cultured in microphysiological systems (MPS) to identify hepatotoxicity.
Chang SY; Voellinger JL; Van Ness KP; Chapron B; Shaffer RM; Neumann T; White CC; Kavanagh TJ; Kelly EJ; Eaton DL
Toxicol In Vitro; 2017 Apr; 40():170-183. PubMed ID: 28089783
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics-On-a-Chip: In Vitro Microphysiological Models for Emulating of Drugs ADME.
Ramadan Q; Fardous RS; Hazaymeh R; Alshmmari S; Zourob M
Adv Biol (Weinh); 2021 Sep; 5(9):e2100775. PubMed ID: 34323392
[TBL] [Abstract][Full Text] [Related]
15. Design and demonstration of a pumpless 14 compartment microphysiological system.
Miller PG; Shuler ML
Biotechnol Bioeng; 2016 Oct; 113(10):2213-27. PubMed ID: 27070809
[TBL] [Abstract][Full Text] [Related]
16. Physiologically Based Pharmacokinetic and Pharmacodynamic Analysis Enabled by Microfluidically Linked Organs-on-Chips.
Prantil-Baun R; Novak R; Das D; Somayaji MR; Przekwas A; Ingber DE
Annu Rev Pharmacol Toxicol; 2018 Jan; 58():37-64. PubMed ID: 29309256
[TBL] [Abstract][Full Text] [Related]
17. [Development of novel culture system using nano-biotechnology].
Taniguchi A; Wada K; Ohno M
Yakugaku Zasshi; 2010 Apr; 130(4):529-35. PubMed ID: 20371998
[TBL] [Abstract][Full Text] [Related]
18. Opportunities and challenges in the wider adoption of liver and interconnected microphysiological systems.
Hughes DJ; Kostrzewski T; Sceats EL
Exp Biol Med (Maywood); 2017 Oct; 242(16):1593-1604. PubMed ID: 28504617
[TBL] [Abstract][Full Text] [Related]
19. Establishing quasi-steady state operations of microphysiological systems (MPS) using tissue-specific metabolic dependencies.
Maass C; Dallas M; LaBarge ME; Shockley M; Valdez J; Geishecker E; Stokes CL; Griffith LG; Cirit M
Sci Rep; 2018 May; 8(1):8015. PubMed ID: 29789564
[TBL] [Abstract][Full Text] [Related]
20. Recent Progress in Hepatocyte Culture Models and Their Application to the Assessment of Drug Metabolism, Transport, and Toxicity in Drug Discovery: The Value of Tissue Engineering for the Successful Development of a Microphysiological System.
Tetsuka K; Ohbuchi M; Tabata K
J Pharm Sci; 2017 Sep; 106(9):2302-2311. PubMed ID: 28533121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
